Abstract

Arrhythmogenic right ventricular cardiomyopathy is a hereditary, rare disease with an increased risk for sudden cardiac death. The disease-causing mutations are located within the desmosomal complex and the highest incidence is found in plakophilin2. However, there are other factors playing a role for the disease progression unrelated to the genotype such as inflammation or exercise. Competitive sports have been identified as risk factor, but the type and extend of physical activity as cofactor for arrhythmogenesis remains under debate. We thus studied the effect of light voluntary exercise on cardiac health in a mouse model. Mice with a heterozygous PKP2 loss-of-function mutation were given the option to exercise in a running wheel which was monitored 24 h/d. We analyzed structural and functional development in vivo by echocardiography which revealed that neither the genotype nor the exercise caused any significant structural changes. Ejection fraction and fractional shortening were not influenced by the genotype itself, but exercise did cause a drop in both parameters after 8 weeks, which returned to normal after 16 weeks of training. The electrophysiological analysis revealed that the arrhythmogenic potential was slightly higher in heterozygous animals (50% vs 18% in wt littermates) and that an additional stressor (isoprenaline) did not lead to an increase of arrhythmogenic events pre run or after 8 weeks of running but the vulnerability was increased after 16 weeks. Exercise-induced alterations in Ca handling and contractility of isolated myocytes were mostly abolished in heterozygous animals. No fibrofatty replacements or rearrangement of gap junctions could be observed. Taken together we could show that light voluntary exercise can cause a transient aggravation of the mutation-induced phenotype which is abolished after long term exercise indicating a beneficial effect of long term light exercise.

Highlights

  • Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a severe cardiac disease, leading to right ventricular dilation with a risk for sudden cardiac death (SCD), ventricular arrhythmias and syncope

  • ARVC is classified as a rare disease, it is moving into the spotlight as it poses a great risk for SCD among young active athletes during exercise

  • ARVC is a hereditary disease with its disease-causing mutations mostly located in desmosomal proteins of which PKP2 has the highest incidence [2] among all identified ARVC cases

Read more

Summary

Introduction

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a severe cardiac disease, leading to right ventricular dilation with a risk for sudden cardiac death (SCD), ventricular arrhythmias and syncope. ARVC is classified as a rare disease, it is moving into the spotlight as it poses a great risk for SCD among young active athletes during exercise. PKP2 running mouse model https://www.ukr.de/ JM: Clinician Scientist by Deutsche Kardiologische Gesellschaft; https://dgk. Org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript PKP2 running mouse model https://www.ukr.de/ JM: Clinician Scientist by Deutsche Kardiologische Gesellschaft; https://dgk. org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.